Opus Genetics, Inc. ( IRD) - Key Metrics
IRD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.08 | -$0.13 | -$0.13 |
| 2026Q1 | $0 | -$0.08 | -$0.01 | -$0.01 |
| 2025Q4 | $0.01 | -$0.03 | -$0.02 | -$0.02 |
| 2025Q3 | $0.04 | -$0.25 | -$0.09 | -$0.09 |
| 2025Q2 | $0.05 | -$0.12 | -$0.16 | -$0.16 |
IRD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -12.84 |
| 2026Q1 | 0% | -1.52 |
| 2025Q4 | 0% | -2.64 |
| 2025Q3 | 0% | -1.65 |
| 2025Q2 | 0% | -1.96 |
IRD
Price: $4.18
52 week price:
Earnings Per Share: -1.29 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 300.3 million